IMU is effectively a gigantic punt on results from trials and nothing else. You are investing in the concept of the treatment and the management team.
At todays prices you are getting $350m of research and development for $100m.
The issue is how much more capital can they raise with the poorly managed corporate function, will the funds exist long enough to determine the drugs potential success.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $239.5K | 21.76M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9709385 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 12254839 | 53 |
View Market Depth
| Last trade - 13.45pm 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |